Common Contracts

INSIDE INFORMATION- ENTERING INTO THE LICENSE AGREEMENT WITH SEAGEN

License Agreement • October 17th, 2020

• Contract Type
  License Agreement
• Filed
  October 17th, 2020

This announcement is made by RemeGen Co., Ltd.* 榮昌生物製藥（煙台）股份有限公司(the “Company”) pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) as well as the Inside Information Provisions (as defined under the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).